The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease
Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significanc...
Saved in:
Published in | Life sciences (1973) Vol. 207; pp. 145 - 151 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Inc
15.08.2018
Elsevier BV |
Subjects | |
Online Access | Get full text |
ISSN | 0024-3205 1879-0631 1879-0631 |
DOI | 10.1016/j.lfs.2018.06.001 |
Cover
Abstract | Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease.
Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis.
Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively.
Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC. |
---|---|
AbstractList | Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease.Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis.Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively.Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC. Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease.OBJECTIVEAlthough angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease.Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis.METHODSAmong patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis.Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively.RESULTSOur data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively.Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC.CONCLUSIONSLower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC. Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease. Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis. Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively. Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC. Objective Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease. Methods Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis. Results Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively. Conclusions Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC. |
Author | Xuan, Wei Fei, Yu Hou, Jianhua Zhang, Chenghua Meng, Xiuping |
Author_xml | – sequence: 1 givenname: Yu surname: Fei fullname: Fei, Yu organization: Department of Cardiology, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun 130041, China – sequence: 2 givenname: Jianhua surname: Hou fullname: Hou, Jianhua organization: Department of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China – sequence: 3 givenname: Wei surname: Xuan fullname: Xuan, Wei organization: Department of Hepatopancreaticobiliary Surgery, China-Japan Union Hospital, Jilin University, Changchun 130041, China – sequence: 4 givenname: Chenghua surname: Zhang fullname: Zhang, Chenghua organization: Department of Endoscopy, Jilin Cancer Hospital, Changchun 130021, China – sequence: 5 givenname: Xiuping surname: Meng fullname: Meng, Xiuping email: mxp208408@sina.com organization: Department of Endodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29870767$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1r3DAQhkVJaTZpf0AvRdBLL3ZHliXZ9FRCvyBQKOlZyPKI1WJLrmQ35N9X200o5JCeNIfnGTTve0HOQgxIyGsGNQMm3x_qyeW6AdbVIGsA9ozsWKf6CiRnZ2QH0LQVb0Cck4ucDwAghOIvyHnTdwqUVDsSb_ZIE05m9THkvV9odHSZTJ4Nnf2PSgCnJozUxhSDSXdlmAqMyUzU-mS3k0l9oEuZMKyZ3vp1_08wqdB3dPQZTcaX5LkzU8ZX9-8l-fn5083V1-r6-5dvVx-vK9uydq0k5-3QqkF0KARXorGc970dnGW944NwcmADdqI3rlwvOgaqG60cW-dG3nLHL8m7094lxV8b5lXPPlssfw8Yt6ybEiBnXPHm_ygIBrJnnBf07SP0ELcUyiHHhW0vmFBQqDf31DbMOOol-bkkoR9SL4A6ATbFnBM6bf36N8c1GT9pBvrYrz7o0q8-9qtB6tJvMdkj82H5U86Hk4Ml798ek862FGVx9Antqsfon7D_ANMCvH4 |
CitedBy_id | crossref_primary_10_1007_s12975_020_00794_0 crossref_primary_10_1186_s12885_018_5017_y crossref_primary_10_1360_SSV_2021_0252 crossref_primary_10_1097_HJH_0000000000002413 crossref_primary_10_2147_DMSO_S262888 crossref_primary_10_1007_s00018_018_2971_0 crossref_primary_10_2174_1568026623666221221124530 crossref_primary_10_3390_biomedicines11041037 crossref_primary_10_15829_1728_8800_2024_4086 crossref_primary_10_3390_jcm13061742 crossref_primary_10_15829_1728_8800_2024_4190 crossref_primary_10_20945_2359_3997000000218 crossref_primary_10_3389_fcvm_2021_770574 crossref_primary_10_1016_j_biocel_2022_106294 crossref_primary_10_3389_fphar_2021_629611 crossref_primary_10_2147_DDDT_S336826 crossref_primary_10_4239_wjd_v13_i11_926 crossref_primary_10_23736_S0026_4725_20_04995_6 |
Cites_doi | 10.1016/S0165-6147(00)01676-X 10.2217/bmm-2016-0282 10.1016/j.vph.2011.06.006 10.1172/JCI42980 10.1016/j.ccep.2017.08.003 10.1161/CIRCULATIONAHA.110.952325 10.1093/cvr/cvn156 10.1155/2016/4285942 10.1371/journal.pone.0000116 10.2337/db15-1668 10.1093/cvr/cvt234 10.1038/nrcardio.2013.207 10.1016/j.jacl.2014.11.003 10.1016/S0002-9149(83)80105-2 10.1016/j.clinbiochem.2012.02.009 10.1093/eurheartj/eht195 10.1111/j.1440-1681.2008.05057.x 10.1161/CIRCRESAHA.108.191270 10.1161/ATVBAHA.112.300142 10.1097/MCA.0000000000000115 10.1016/j.phrs.2012.09.005 10.1016/j.yjmcc.2011.12.006 10.1096/fj.201700617R 10.1038/nm.3040 10.1093/cvr/cvv104 10.1016/j.canlet.2013.01.028 |
ContentType | Journal Article |
Copyright | 2018 Copyright © 2018. Published by Elsevier Inc. Copyright Elsevier BV Aug 15, 2018 |
Copyright_xml | – notice: 2018 – notice: Copyright © 2018. Published by Elsevier Inc. – notice: Copyright Elsevier BV Aug 15, 2018 |
DBID | AAYXX CITATION NPM 7QP 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 RC3 7X8 7S9 L.6 |
DOI | 10.1016/j.lfs.2018.06.001 |
DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef PubMed Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic PubMed Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Biology |
EISSN | 1879-0631 |
EndPage | 151 |
ExternalDocumentID | 29870767 10_1016_j_lfs_2018_06_001 S0024320518303424 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 4.4 457 5GY 5RE 5VS 6TJ 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXUO ABFNM ABFRF ABJNI ABLJU ABLVK ABMAC ABMZM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACIWK ACPRK ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFRAH AFTJW AFXIZ AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV C45 CNWQP CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IH2 IHE J1W K-O KOM L7B LCYCR M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SDP SES SPCBC SSH SSP SSZ T5K TEORI YZZ ~G- .55 .GJ 29L 3O- 53G AAHBH AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ABXDB ACIEU ACLOT ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFFNX AFJKZ AFPUW AGHFR AGQPQ AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CITATION EFKBS FEDTE FGOYB G-2 HMG HMT HVGLF HZ~ H~9 J5H MVM R2- SEW SIN SPT WUQ X7M Y6R YYP ZGI ZKB ZXP ZY4 ~HD NPM 7QP 7QR 7TK 7U7 7U9 8FD AGCQF C1K FR3 H94 P64 RC3 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c414t-6334b47b58e553752c3399cbfc19f3b5f6b1be859af018581078dc6d4ffd343f3 |
IEDL.DBID | .~1 |
ISSN | 0024-3205 1879-0631 |
IngestDate | Sun Sep 28 12:35:40 EDT 2025 Sat Sep 27 22:09:46 EDT 2025 Wed Aug 13 11:22:24 EDT 2025 Wed Feb 19 02:41:46 EST 2025 Wed Oct 01 05:07:44 EDT 2025 Thu Apr 24 23:01:42 EDT 2025 Fri Feb 23 02:25:40 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | VEGF-A Gensini score Coronary collateral circulation miR-503 Rentrop grade |
Language | English |
License | Copyright © 2018. Published by Elsevier Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c414t-6334b47b58e553752c3399cbfc19f3b5f6b1be859af018581078dc6d4ffd343f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 29870767 |
PQID | 2104951570 |
PQPubID | 2045439 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2101313732 proquest_miscellaneous_2051069133 proquest_journals_2104951570 pubmed_primary_29870767 crossref_citationtrail_10_1016_j_lfs_2018_06_001 crossref_primary_10_1016_j_lfs_2018_06_001 elsevier_sciencedirect_doi_10_1016_j_lfs_2018_06_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-08-15 |
PublicationDateYYYYMMDD | 2018-08-15 |
PublicationDate_xml | – month: 08 year: 2018 text: 2018-08-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: New York |
PublicationTitle | Life sciences (1973) |
PublicationTitleAlternate | Life Sci |
PublicationYear | 2018 |
Publisher | Elsevier Inc Elsevier BV |
Publisher_xml | – name: Elsevier Inc – name: Elsevier BV |
References | Wang, Yan, Song (bb0045) 2017; 11 Wang, Qian, Zhang (bb0070) 2009; 36 Prosser, Tan, Dunn (bb0125) 2013; 101 Dang, Lawson, Fish (bb0035) 2013; 33 Hua, Lv, Ye (bb0110) 2006; 1 Khoo, Shen, Zhao (bb0075) 2014; 25 Zimarino, D'andreamatteo, Waksman (bb0015) 2014; 11 Tan, Ng, Bursill (bb0120) 2015; 106 Zhou, Ma, Si (bb0050) 2013; 333 Foussas, Tsiaousis (bb0010) 2008; 12 Gensini (bb0085) 1983; 51 Jin, Hagemann, Sun (bb0140) 2018 Caporali, Emanueli (bb0025) 2011; 55 Cannizzo, Adonopulos, Solly (bb0145) 2018; 32 Caporali, Meloni, Völlenkle (bb0055) 2011; 123 Kim, Kang, Kojima (bb0060) 2013; 19 Tan, Prosser, Dunn (bb0135) 2016; 65 Tomasetti, Staffolani, Nocchi (bb0080) 2012; 45 Cross, Claesson-Welsh (bb0105) 2001; 22 Muñoz-Pacheco, Ortega-Hernández, Miana (bb0065) 2012; 66 Suarez, Sessa (bb0030) 2009; 104 Ghosh, Subramanian, Adhikari (bb0100) 2010; 120 Wang, Yan, Song (bb0115) 2016; 2016 Sayın, Çetiner, Karabağ (bb0090) 2012 Xu, Li, Li (bb0150) 2015; 9 Chilian, Penn, Pung (bb0095) 2012; 52 Urbich, Kuehbacher, Dimmeler (bb0040) 2008; 79 El-Sherif, Boutjdir, Turitto (bb0005) 2017; 9 Seiler, Stoller, Pitt (bb0020) 2013; 34 Zimarino (10.1016/j.lfs.2018.06.001_bb0015) 2014; 11 Muñoz-Pacheco (10.1016/j.lfs.2018.06.001_bb0065) 2012; 66 Kim (10.1016/j.lfs.2018.06.001_bb0060) 2013; 19 Caporali (10.1016/j.lfs.2018.06.001_bb0025) 2011; 55 El-Sherif (10.1016/j.lfs.2018.06.001_bb0005) 2017; 9 Wang (10.1016/j.lfs.2018.06.001_bb0070) 2009; 36 Tomasetti (10.1016/j.lfs.2018.06.001_bb0080) 2012; 45 Gensini (10.1016/j.lfs.2018.06.001_bb0085) 1983; 51 Jin (10.1016/j.lfs.2018.06.001_bb0140) 2018 Wang (10.1016/j.lfs.2018.06.001_bb0045) 2017; 11 Xu (10.1016/j.lfs.2018.06.001_bb0150) 2015; 9 Suarez (10.1016/j.lfs.2018.06.001_bb0030) 2009; 104 Khoo (10.1016/j.lfs.2018.06.001_bb0075) 2014; 25 Hua (10.1016/j.lfs.2018.06.001_bb0110) 2006; 1 Seiler (10.1016/j.lfs.2018.06.001_bb0020) 2013; 34 Urbich (10.1016/j.lfs.2018.06.001_bb0040) 2008; 79 Prosser (10.1016/j.lfs.2018.06.001_bb0125) 2013; 101 Caporali (10.1016/j.lfs.2018.06.001_bb0055) 2011; 123 Tan (10.1016/j.lfs.2018.06.001_bb0120) 2015; 106 Cross (10.1016/j.lfs.2018.06.001_bb0105) 2001; 22 Zhou (10.1016/j.lfs.2018.06.001_bb0050) 2013; 333 Sayın (10.1016/j.lfs.2018.06.001_bb0090) 2012 Tan (10.1016/j.lfs.2018.06.001_bb0135) 2016; 65 Foussas (10.1016/j.lfs.2018.06.001_bb0010) 2008; 12 Cannizzo (10.1016/j.lfs.2018.06.001_bb0145) 2018; 32 Ghosh (10.1016/j.lfs.2018.06.001_bb0100) 2010; 120 Dang (10.1016/j.lfs.2018.06.001_bb0035) 2013; 33 Chilian (10.1016/j.lfs.2018.06.001_bb0095) 2012; 52 Wang (10.1016/j.lfs.2018.06.001_bb0115) 2016; 2016 |
References_xml | – volume: 123 start-page: 282 year: 2011 end-page: 291 ident: bb0055 article-title: Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia publication-title: Circulation – volume: 19 start-page: 74 year: 2013 end-page: 82 ident: bb0060 article-title: An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension[J] publication-title: Nat. Med. – volume: 79 start-page: 581 year: 2008 end-page: 588 ident: bb0040 article-title: Role of microRNAs in vascular diseases, inflammation, and angiogenesis[J] publication-title: Cardiovasc. Res. – volume: 32 start-page: 2911 year: 2018 end-page: 2922 ident: bb0145 article-title: VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia[J] publication-title: FASEB J. – volume: 34 start-page: 2674 year: 2013 end-page: 2682 ident: bb0020 article-title: The human coronary collateral circulation: development and clinical importance[J] publication-title: Eur. Heart J. – volume: 25 start-page: 493 year: 2014 end-page: 497 ident: bb0075 article-title: Determination of the severity of underlying lesions in acute myocardial infarction on the basis of collateral vessel development[J] publication-title: Coron. Artery Dis. – volume: 2016 year: 2016 ident: bb0115 article-title: Reduced plasma miR-146a is a predictor of poor coronary collateral circulation in patients with coronary artery disease[J] publication-title: Biomed. Res. Int. – volume: 45 start-page: 575 year: 2012 end-page: 581 ident: bb0080 article-title: Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients[J] publication-title: Clin. Biochem. – volume: 55 start-page: 79 year: 2011 end-page: 86 ident: bb0025 article-title: MicroRNA regulation in angiogenesis[J] publication-title: Vasc. Pharmacol. – volume: 104 start-page: 442 year: 2009 end-page: 454 ident: bb0030 article-title: MicroRNAs as novel regulators of angiogenesis[J] publication-title: Circ. Res. – volume: 11 start-page: 191 year: 2014 end-page: 197 ident: bb0015 article-title: The dynamics of the coronary collateral circulation[J] publication-title: Nat. Rev. Cardiol. – volume: 120 start-page: 4141 year: 2010 end-page: 4154 ident: bb0100 article-title: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis[J] publication-title: J. Clin. Invest. – volume: 1 year: 2006 ident: bb0110 article-title: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia[J] publication-title: PLoS One – volume: 11 start-page: 125 year: 2017 end-page: 131 ident: bb0045 article-title: The association of plasma miR-155 and VCAM-1 levels with coronary collateral circulation[J] publication-title: Biomark. Med – volume: 33 start-page: 193 year: 2013 end-page: 200 ident: bb0035 article-title: MicroRNA control of vascular endothelial growth factor signaling output during vascular development[J] publication-title: Arterioscler. Thromb. Vasc. Biol. – start-page: 1 year: 2018 end-page: 14 ident: bb0140 article-title: High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation[J] publication-title: Angiogenesis – volume: 101 start-page: 145 year: 2013 end-page: 154 ident: bb0125 article-title: Multifunctional regulation of angiogenesis by high-density lipoproteins[J] publication-title: Cardiovasc. Res. – volume: 9 start-page: 681 year: 2017 end-page: 691 ident: bb0005 article-title: Sudden cardiac death in ischemic heart disease: pathophysiology and risk stratification[J] publication-title: Card. Electrophysiol. Clin. – volume: 12 start-page: 3 year: 2008 end-page: 10 ident: bb0010 article-title: Revascularization treatment in patients with coronary artery disease[J] publication-title: Hippokratia – volume: 36 start-page: 181 year: 2009 end-page: 188 ident: bb0070 article-title: MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats[J] publication-title: Clin. Exp. Pharmacol. Physiol. – volume: 22 start-page: 201 year: 2001 end-page: 207 ident: bb0105 article-title: FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition[J] publication-title: Trends Pharmacol. Sci. – volume: 66 start-page: 536 year: 2012 end-page: 543 ident: bb0065 article-title: Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism[J] publication-title: Pharmacol. Res. – volume: 52 start-page: 905 year: 2012 end-page: 911 ident: bb0095 article-title: Coronary collateral growth—back to the future[J] publication-title: J. Mol. Cell. Cardiol. – start-page: 51 year: 2012 end-page: 54 ident: bb0090 article-title: The Relationship Between the Gensini Score and Complete Blood Count Parameters in Coronary Artery Disease[J] – volume: 9 start-page: 26 year: 2015 end-page: 34 ident: bb0150 article-title: High-density lipoprotein subfractions in relation with the severity of coronary artery disease: a Gensini score assessment[J] publication-title: J. Clin. Lipidol. – volume: 65 start-page: 3091 year: 2016 end-page: 3103 ident: bb0135 article-title: High-density lipoproteins rescue diabetes-impaired angiogenesis via scavenger receptor class B type I[J] publication-title: Diabetes – volume: 51 start-page: 606 year: 1983 ident: bb0085 article-title: A more meaningful scoring system for determining the severity of coronary heart disease[J] publication-title: Am. J. Cardiol. – volume: 106 start-page: 184 year: 2015 end-page: 193 ident: bb0120 article-title: The role of high-density lipoproteins in the regulation of angiogenesis[J] publication-title: Cardiovasc. Res. – volume: 333 start-page: 159 year: 2013 end-page: 169 ident: bb0050 article-title: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth[J] publication-title: Cancer Lett. – volume: 22 start-page: 201 issue: 4 year: 2001 ident: 10.1016/j.lfs.2018.06.001_bb0105 article-title: FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition[J] publication-title: Trends Pharmacol. Sci. doi: 10.1016/S0165-6147(00)01676-X – volume: 12 start-page: 3 issue: 1 year: 2008 ident: 10.1016/j.lfs.2018.06.001_bb0010 article-title: Revascularization treatment in patients with coronary artery disease[J] publication-title: Hippokratia – volume: 11 start-page: 125 issue: 2 year: 2017 ident: 10.1016/j.lfs.2018.06.001_bb0045 article-title: The association of plasma miR-155 and VCAM-1 levels with coronary collateral circulation[J] publication-title: Biomark. Med doi: 10.2217/bmm-2016-0282 – volume: 55 start-page: 79 issue: 4 year: 2011 ident: 10.1016/j.lfs.2018.06.001_bb0025 article-title: MicroRNA regulation in angiogenesis[J] publication-title: Vasc. Pharmacol. doi: 10.1016/j.vph.2011.06.006 – volume: 120 start-page: 4141 issue: 11 year: 2010 ident: 10.1016/j.lfs.2018.06.001_bb0100 article-title: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis[J] publication-title: J. Clin. Invest. doi: 10.1172/JCI42980 – volume: 9 start-page: 681 issue: 4 year: 2017 ident: 10.1016/j.lfs.2018.06.001_bb0005 article-title: Sudden cardiac death in ischemic heart disease: pathophysiology and risk stratification[J] publication-title: Card. Electrophysiol. Clin. doi: 10.1016/j.ccep.2017.08.003 – volume: 123 start-page: 282 year: 2011 ident: 10.1016/j.lfs.2018.06.001_bb0055 article-title: Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.952325 – volume: 79 start-page: 581 issue: 4 year: 2008 ident: 10.1016/j.lfs.2018.06.001_bb0040 article-title: Role of microRNAs in vascular diseases, inflammation, and angiogenesis[J] publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvn156 – start-page: 1 year: 2018 ident: 10.1016/j.lfs.2018.06.001_bb0140 article-title: High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation[J] publication-title: Angiogenesis – volume: 2016 year: 2016 ident: 10.1016/j.lfs.2018.06.001_bb0115 article-title: Reduced plasma miR-146a is a predictor of poor coronary collateral circulation in patients with coronary artery disease[J] publication-title: Biomed. Res. Int. doi: 10.1155/2016/4285942 – volume: 1 issue: 1 year: 2006 ident: 10.1016/j.lfs.2018.06.001_bb0110 article-title: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia[J] publication-title: PLoS One doi: 10.1371/journal.pone.0000116 – volume: 65 start-page: 3091 issue: 10 year: 2016 ident: 10.1016/j.lfs.2018.06.001_bb0135 article-title: High-density lipoproteins rescue diabetes-impaired angiogenesis via scavenger receptor class B type I[J] publication-title: Diabetes doi: 10.2337/db15-1668 – volume: 101 start-page: 145 issue: 1 year: 2013 ident: 10.1016/j.lfs.2018.06.001_bb0125 article-title: Multifunctional regulation of angiogenesis by high-density lipoproteins[J] publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvt234 – volume: 11 start-page: 191 issue: 4 year: 2014 ident: 10.1016/j.lfs.2018.06.001_bb0015 article-title: The dynamics of the coronary collateral circulation[J] publication-title: Nat. Rev. Cardiol. doi: 10.1038/nrcardio.2013.207 – volume: 9 start-page: 26 issue: 1 year: 2015 ident: 10.1016/j.lfs.2018.06.001_bb0150 article-title: High-density lipoprotein subfractions in relation with the severity of coronary artery disease: a Gensini score assessment[J] publication-title: J. Clin. Lipidol. doi: 10.1016/j.jacl.2014.11.003 – volume: 51 start-page: 606 issue: 3 year: 1983 ident: 10.1016/j.lfs.2018.06.001_bb0085 article-title: A more meaningful scoring system for determining the severity of coronary heart disease[J] publication-title: Am. J. Cardiol. doi: 10.1016/S0002-9149(83)80105-2 – start-page: 51 year: 2012 ident: 10.1016/j.lfs.2018.06.001_bb0090 – volume: 45 start-page: 575 issue: 7–8 year: 2012 ident: 10.1016/j.lfs.2018.06.001_bb0080 article-title: Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients[J] publication-title: Clin. Biochem. doi: 10.1016/j.clinbiochem.2012.02.009 – volume: 34 start-page: 2674 issue: 34 year: 2013 ident: 10.1016/j.lfs.2018.06.001_bb0020 article-title: The human coronary collateral circulation: development and clinical importance[J] publication-title: Eur. Heart J. doi: 10.1093/eurheartj/eht195 – volume: 36 start-page: 181 issue: 2 year: 2009 ident: 10.1016/j.lfs.2018.06.001_bb0070 article-title: MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats[J] publication-title: Clin. Exp. Pharmacol. Physiol. doi: 10.1111/j.1440-1681.2008.05057.x – volume: 104 start-page: 442 issue: 4 year: 2009 ident: 10.1016/j.lfs.2018.06.001_bb0030 article-title: MicroRNAs as novel regulators of angiogenesis[J] publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.108.191270 – volume: 33 start-page: 193 issue: 2 year: 2013 ident: 10.1016/j.lfs.2018.06.001_bb0035 article-title: MicroRNA control of vascular endothelial growth factor signaling output during vascular development[J] publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.112.300142 – volume: 25 start-page: 493 issue: 6 year: 2014 ident: 10.1016/j.lfs.2018.06.001_bb0075 article-title: Determination of the severity of underlying lesions in acute myocardial infarction on the basis of collateral vessel development[J] publication-title: Coron. Artery Dis. doi: 10.1097/MCA.0000000000000115 – volume: 66 start-page: 536 issue: 6 year: 2012 ident: 10.1016/j.lfs.2018.06.001_bb0065 article-title: Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism[J] publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2012.09.005 – volume: 52 start-page: 905 issue: 4 year: 2012 ident: 10.1016/j.lfs.2018.06.001_bb0095 article-title: Coronary collateral growth—back to the future[J] publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2011.12.006 – volume: 32 start-page: 2911 issue: 6 year: 2018 ident: 10.1016/j.lfs.2018.06.001_bb0145 article-title: VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia[J] publication-title: FASEB J. doi: 10.1096/fj.201700617R – volume: 19 start-page: 74 issue: 1 year: 2013 ident: 10.1016/j.lfs.2018.06.001_bb0060 article-title: An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension[J] publication-title: Nat. Med. doi: 10.1038/nm.3040 – volume: 106 start-page: 184 issue: 2 year: 2015 ident: 10.1016/j.lfs.2018.06.001_bb0120 article-title: The role of high-density lipoproteins in the regulation of angiogenesis[J] publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvv104 – volume: 333 start-page: 159 issue: 2 year: 2013 ident: 10.1016/j.lfs.2018.06.001_bb0050 article-title: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth[J] publication-title: Cancer Lett. doi: 10.1016/j.canlet.2013.01.028 |
SSID | ssj0005573 |
Score | 2.3684125 |
Snippet | Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they... Objective Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 145 |
SubjectTerms | angiogenesis Angiography Biomarkers Cardiovascular disease Coronary artery Coronary artery disease Coronary collateral circulation coronary vessels Correlation enzyme-linked immunosorbent assay Gensini score miR-503 patients Plasma prognosis Proteins Regression analysis Rentrop grade reverse transcriptase polymerase chain reaction Ribonucleic acid RNA Sensitivity vascular endothelial growth factor A VEGF-A |
Title | The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease |
URI | https://dx.doi.org/10.1016/j.lfs.2018.06.001 https://www.ncbi.nlm.nih.gov/pubmed/29870767 https://www.proquest.com/docview/2104951570 https://www.proquest.com/docview/2051069133 https://www.proquest.com/docview/2101313732 |
Volume | 207 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1879-0631 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005573 issn: 0024-3205 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1879-0631 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005573 issn: 0024-3205 databaseCode: ACRLP dateStart: 19950526 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1879-0631 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005573 issn: 0024-3205 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1879-0631 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005573 issn: 0024-3205 databaseCode: AIKHN dateStart: 19950526 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-0631 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005573 issn: 0024-3205 databaseCode: AKRWK dateStart: 19930101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CSqGX0KRtsmkaVOghLThZeSTLPobQsG0hh5JAbsaSJeKw8S6bzWEv_e2dseVtC-0eerQsGVnzlGb0DcCHXJIXqqxKjDOYKIeeZI7kSmldB68sNXRon1fZ5EZ9vdW3W3Ax3IXhtMqo-3ud3mnr2HIWV_Ns3jR8xzdVmBJT5cg4dowJyuhfxNOnP35L89AxypyqhHsPkc0ux2saGLFb9hCesS7MX2zTv3zPzgZdvoSd6DyK835-u7Dl2z143peTXO3BbhTUR3ES0aQ_voIZMYJYDClvd81czIKYk8_8UImH5nuixyiqthaOoQyqxUp0nMH3kqfCNQsXy3uJphURg_VR8OHtrwFdVuhKxFDPa7i5_Hx9MUlilYXEKamWSYZItDJW515rNDp1SE6Ls8HJIqDVIbPS-lwXVaCV0jntF_PaZbUKoUaFAd_Adjtr_QEI6TTZO23Jq0GVV86idGmtCpN6HPtqPILxsL6lixDkXAljWg65ZvclkaRkkpR9vt0IPq2HzHv8jU2d1UC08g8mKsk-bBp2NBC4jBJM72mfSt6nNjTr9-vXJHscUKlaP3vib5BGywra5m_oIxnRCA2mI9jvmWf9I2lB2tJk5vD_5v0WXvATn3BLfQTby8WTf0cu0tIedzJwDM_Ov3ybXP0EI6wNzw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED-xomm8TIN9dbDNk_awTYqoc3acPCIEKoP1YQKJNyt2bC1TSatSHvrfc06cIqStD7zavsjxffjsO_8O4GvOyQsVRiTKKkyERUc6R3olpKy8E4YaWrTPSTa-Ej-v5fUWHPdvYUJaZbT9nU1vrXVsOYyreTiv6_DGNxWYklDlGHDsxDPYFpJs8gC2j87Ox5OHTA8ZA82pSAJBH9xs07ymPoB28w7FM5aG-cf29D_3s92GTl_By-g_sqNuiruw5Zo9eN5VlFztwW7U1Vv2LQJKf38NM5IFtuiz3v7UczbzbE5u803JburfiRwhK5uK2YBmUC5WrBWO8DR5ymy9sLHCF6sbFmFYb1m4v30gaBNDVyxGe97A1enJ5fE4iYUWEiu4WCYZIrFLGZk7KVHJ1CL5LdZ4ywuPRvrMcONyWZSeVkrmdGTMK5tVwvsKBXp8C4Nm1rj3wLiVtOVJQ44Niry0BrlNK1Go1OHIlaMhjPr11TaikIdiGFPdp5v91cQSHViiu5S7IfxYk8w7CI5Ng0XPNP1IjjRtEZvIDnoG66jE1E9HVXJApaJZf1l3k_qFmErZuNld-AYZtaygk_6GMTyAGqHCdAjvOuFZ_0hakMFUmfrwtHl_hhfjy18X-uJscr4PO6EnXHhzeQCD5eLOfSSPaWk-RY24B0igEHo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relationship+of+plasma+miR-503+and+coronary+collateral+circulation+in+patients+with+coronary+artery+disease&rft.jtitle=Life+sciences+%281973%29&rft.au=Fei%2C+Yu&rft.au=Hou%2C+Jianhua&rft.au=Xuan%2C+Wei&rft.au=Zhang%2C+Chenghua&rft.date=2018-08-15&rft.issn=0024-3205&rft.volume=207+p.145-151&rft.spage=145&rft.epage=151&rft_id=info:doi/10.1016%2Fj.lfs.2018.06.001&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0024-3205&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0024-3205&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0024-3205&client=summon |